{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:45:20Z","timestamp":1792043120934,"version":"4.4.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40257-020-00503-5","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T05:02:26Z","timestamp":1580533346000},"page":"355-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments"],"prefix":"10.1007","volume":"21","author":[{"given":"Magdalena","family":"Misiak-Galazka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Zozula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-1023","authenticated-orcid":false,"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"issue":"5","key":"503_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.2011.10233.x","volume":"164","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, Van De Kerkhof PCM. Management of palmoplantar pustulosis: do we need to change? Br J Dermatol. 2011;164(5):942\u20136.","journal-title":"Br J Dermatol."},{"issue":"1","key":"503_CR2","doi-asserted-by":"publisher","first-page":"e006450","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open. 2015;5(1):e006450.","journal-title":"BMJ Open."},{"issue":"4","key":"503_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","volume":"156","author":"G Micha\u00eblsson","year":"2007","unstructured":"Micha\u00eblsson G, Kristj\u00e1nsson G, Pihl Lundin I, Hagforsen E. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol. 2007;156(4):659\u201366.","journal-title":"Br J Dermatol."},{"issue":"7","key":"503_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","volume":"23","author":"E Adisen","year":"2009","unstructured":"Adisen E, Tekin O, Gulekon A, Gurer MA. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol. 2009;23(7):814\u20139.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"6","key":"503_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/bjd.12223","volume":"168","author":"AMG Brunasso","year":"2013","unstructured":"Brunasso AMG, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol. 2013;168(6):1243\u201351.","journal-title":"Br J Dermatol."},{"issue":"3","key":"503_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1046\/j.1365-2133.1998.02113.x","volume":"138","author":"MO Eriksson","year":"1998","unstructured":"Eriksson MO, Hagforsen E, Lundin IP, Micha\u00eblsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol. 1998;138(3):390\u20138.","journal-title":"Br J Dermatol."},{"issue":"2","key":"503_CR7","first-page":"109","volume":"26","author":"M Misiak-Galazka","year":"2018","unstructured":"Misiak-Galazka M, Wolska H, Galazka A, Kwiek B, Rudnicka L. General characteristics and comorbidities in patients with palmoplantar pustulosis. Acta Dermatovenerol Croat. 2018;26(2):109\u201318.","journal-title":"Acta Dermatovenerol Croat."},{"issue":"10","key":"503_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1468-3083.2009.03282.x","volume":"23","author":"H Miot","year":"2009","unstructured":"Miot H, Miot L, Lopes P, Haddad G, Marques S. Association between palmoplantar pustulosis and cigarette smoking in Brazil: a case\u2013control study. J Eur Acad Dermatol Venereol. 2009;23(10):1173\u20137.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"503_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D3234034627","volume":"23","author":"D Wilsmann-Theis","year":"2017","unstructured":"Wilsmann-Theis D, Jacobi A, Frambach Y, Philipp S, Weyergraf A, Schill T, et al. Palmoplantar pustulosis\u2014a cross-sectional analysis in Germany. Dermatol Online J. 2017;23:4.","journal-title":"Dermatol Online J."},{"issue":"6","key":"503_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2133.1996.tb07946.x","volume":"134","author":"AD Burden","year":"1996","unstructured":"Burden AD, Kemmett D. The spectrum of nail involvement in palmoplantar pustulosis. Br J Dermatol. 1996;134(6):1079\u201382.","journal-title":"Br J Dermatol."},{"issue":"2","key":"503_CR11","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/ijd.13224","volume":"56","author":"T Hiraiwa","year":"2017","unstructured":"Hiraiwa T, Yamamoto T. Nail involvement associated with palmoplantar pustulosis. Int J Dermatol. 2017;56(2):e28\u20139.","journal-title":"Int J Dermatol."},{"issue":"3","key":"503_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1468-3083.2003.00510.x","volume":"17","author":"R Gimen\u00e9z-Garc\u00eda","year":"2003","unstructured":"Gimen\u00e9z-Garc\u00eda R, S\u00e1nchez-Ram\u00f3n S, Cuellar-Olmedo LA. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol. 2003;17(3):276\u20139.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"7","key":"503_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/1346-8138.14348","volume":"45","author":"M Takahara","year":"2018","unstructured":"Takahara M, Hirata Y, Nagato T, Kishibe K, Katada A, Hayashi T, et al. Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: a retrospective subjective and objective quantitative analysis of 138 patients. J Dermatol. 2018;45(7):812\u201323.","journal-title":"J Dermatol."},{"issue":"1","key":"503_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.clim.2005.01.009","volume":"116","author":"H Nozawa","year":"2005","unstructured":"Nozawa H, Kishibe K, Takahara M, Harabuchi Y. Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP). Clin Immunol. 2005;116(1):42\u201353.","journal-title":"Clin Immunol."},{"issue":"6","key":"503_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/1346-8138.13751","volume":"44","author":"M Kouno","year":"2017","unstructured":"Kouno M, Nishiyama A, Minabe M, Iguchi N, Ukichi K, Nomura T, et al. Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal. J Dermatol. 2017;44(6):695\u20138.","journal-title":"J Dermatol."},{"issue":"4","key":"503_CR16","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1111\/jdv.15434","volume":"33","author":"Y Masui","year":"2019","unstructured":"Masui Y, Ito A, Akiba Y, Uoshima K, Abe R. Dental metal allergy is not the main cause of palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2019;33(4):e180\u20131.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"503_CR17","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1111\/ijd.12242","volume":"53","author":"T Ito","year":"2014","unstructured":"Ito T, Mori T, Fujiyama T, Tokura Y. Dramatic exacerbation of palmoplantar pustulosis following strongly positive nickel patch testing. Int J Dermatol. 2014;53(5):e327\u20139.","journal-title":"Int J Dermatol."},{"issue":"9490","key":"503_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(05)67384-9","volume":"366","author":"T Yanagi","year":"2005","unstructured":"Yanagi T, Shimizu T, Abe R, Shimizu H. Zinc dental fillings and palmoplantar pustulosis. Lancet. 2005;366(9490):1050.","journal-title":"Lancet."},{"issue":"SUPPL. 7","key":"503_CR19","first-page":"251","volume":"31","author":"K Watanabe","year":"1989","unstructured":"Watanabe K, Sugai T, Shoji A, Asoh S, Hashimoto Y, Inoue A. Metal allergy in patients with palmoplantar pustulosis. Skin Res. 1989;31(SUPPL. 7):251\u20136.","journal-title":"Skin Res."},{"issue":"1","key":"503_CR20","first-page":"53","volume":"19","author":"M Hosoki","year":"2009","unstructured":"Hosoki M, Bando E, Asaoka K, Takeuchi H, Nishigawa K. Assessment of allergic hypersensitivity to dental materials. Biomed Mater Eng. 2009;19(1):53\u201361.","journal-title":"Biomed Mater Eng."},{"issue":"2","key":"503_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5826\/dpc.0902a05","volume":"9","author":"AMG Brunasso Vernetti","year":"2019","unstructured":"Brunasso Vernetti AMG, Puntoni M, Massone C. Palmoplantar pustulosis and allergies: a systematic review. Dermatol Pract Concept. 2019;9(2):105\u201310.","journal-title":"Dermatol Pract Concept."},{"issue":"2","key":"503_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/apt.14822","volume":"48","author":"JM Bae","year":"2018","unstructured":"Bae JM, Lee HH, Lee BI, Lee KM, Eun SH, Cho ML, et al. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2018;48(2):196\u2013205.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"503_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1468-3083.2010.03648.x","volume":"24","author":"AMG Brunasso","year":"2010","unstructured":"Brunasso AMG, Massone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol. 2010;24(5):619\u201321.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"3","key":"503_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5114\/pdia.2016.61630","volume":"34","author":"H Ata\u015f","year":"2017","unstructured":"Ata\u015f H, G\u00f6n\u00fcl M. Insulin resistance, diabetes mellitus and thyroid dysfunction in patients with palmoplantar pustulosis: a case\u2013controlled study. Post Dermatol Alergol. 2017;34(3):268\u201372.","journal-title":"Post Dermatol Alergol."},{"issue":"10","key":"503_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/jdv.14187","volume":"31","author":"H Trattner","year":"2017","unstructured":"Trattner H, Bl\u00fcml S, Steiner I, Plut U, Radakovic S, Tanew A. Quality of life and comorbidities in palmoplantar pustulosis\u2014a cross-sectional study on 102 patients. J Eur Acad Dermatol Venereol. 2017;31(10):1681\u20135.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"9","key":"503_CR26","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1111\/jdv.12545","volume":"29","author":"G Becher","year":"2015","unstructured":"Becher G, Jamieson L, Leman J. Palmoplantar pustulosis\u2014a retrospective review of comorbid conditions. J Eur Acad Dermatol Venereol. 2015;29(9):1854\u20136.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"503_CR27","first-page":"613","volume":"115","author":"C Benhamou","year":"1988","unstructured":"Benhamou C, Chamot AM, Kahn MF. SAPHO syndrome. Ann Dermatol Venereol. 1988;115(5):613\u20138.","journal-title":"Ann Dermatol Venereol."},{"issue":"3","key":"503_CR28","first-page":"225","volume":"85","author":"E Hagforsen","year":"2005","unstructured":"Hagforsen E, Michaelsson K, Lundgren E, Olofsson H, Petersson A, Lagumdzija A, et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case\u2013control study. Acta Derm Venereol. 2005;85(3):225\u201332.","journal-title":"Acta Derm Venereol."},{"issue":"5","key":"503_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5114\/ada.2016.62838","volume":"33","author":"A Lesiak","year":"2016","unstructured":"Lesiak A, Bednarski I, Pa\u0142czy\u0144ska M, Kumiszcza E, Kraska-Gacka M, Wo\u017aniacka A, et al. Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis? Post Dermatol Alergol. 2016;33(5):336\u20139.","journal-title":"Post Dermatol Alergol."},{"issue":"6","key":"503_CR30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/j.1365-2133.2007.07908.x","volume":"156","author":"P Weisenseel","year":"2007","unstructured":"Weisenseel P, Kuznetsov AV, Ruzicka T, Prinz JC. Palmoplantar pustulosis is not inevitably associated with antigliadin antibodies. Br J Dermatol. 2007;156(6):1399\u2013400.","journal-title":"Br J Dermatol."},{"issue":"4","key":"503_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jaad.2014.04.063","volume":"71","author":"J Chung","year":"2014","unstructured":"Chung J, Duffin KC, Takeshita J, Shin DB, Krueger GG, Robertson AD, et al. Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2014;71(4):623\u201332.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"503_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1067\/S0190-9622(03)01479-8","volume":"49","author":"AA Pettey","year":"2003","unstructured":"Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol. 2003;49(2):271\u20135.","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"503_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1365-2133.2005.07071.x","volume":"154","author":"F Sampogna","year":"2006","unstructured":"Sampogna F, Tabolli S, S\u00f6derfeldt B, Axtelius B, Aparo U, Abeni D. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol. 2006;154(5):844\u20139.","journal-title":"Br J Dermatol."},{"issue":"6","key":"503_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaad.2008.11.910","volume":"60","author":"E Farley","year":"2009","unstructured":"Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol. 2009;60(6):1024\u201331.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"503_CR35","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.18632\/oncotarget.22814","volume":"9","author":"L Ding","year":"2018","unstructured":"Ding L, Wang X, Hong X, Lu L, Liu D. IL-36 cytokines in autoimmunity and inflammatory disease. Oncotarget. 2018;9(2):2895\u2013901.","journal-title":"Oncotarget."},{"issue":"5","key":"503_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","volume":"94","author":"N Setta-Kaffetzi","year":"2014","unstructured":"Setta-Kaffetzi N, Simpson MA, Navarini AA, Patel VM, Lu HC, Allen MH, et al. AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet. 2014;94(5):790\u20137.","journal-title":"Am J Hum Genet."},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3389\/fimmu.2018.02167","volume":"9","author":"T Zotti","year":"2018","unstructured":"Zotti T, Polvere I, Voccola S, Vito P, Stilo R. CARD14\/CARMA2 signaling and its role in inflammatory skin disorders. Front Immunol. 2018;9:2167.","journal-title":"Front Immunol."},{"issue":"7","key":"503_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med."},{"issue":"3","key":"503_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"A Onoufriadis","year":"2011","unstructured":"Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89(3):432\u20137.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"503_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000346572","volume":"226","author":"O Abbas","year":"2013","unstructured":"Abbas O, Itani S, Ghosn S, Kibbi AG, Fidawi G, Farooq M, et al. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis. Dermatology. 2013;226(1):28\u201331.","journal-title":"Dermatology."},{"issue":"3","key":"503_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjd.15867","volume":"178","author":"R Mossner","year":"2018","unstructured":"Mossner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Lohr S, Schulz P, et al. The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. 2018;178(3):740\u20138.","journal-title":"Br J Dermatol."},{"issue":"1","key":"503_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1346-8138.13551","volume":"44","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Fujimoto N, Kabuto M, Nakanishi T, Tanaka T. Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis. J Dermatol. 2017;44(1):80\u20133.","journal-title":"J Dermatol."},{"issue":"1","key":"503_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00403-015-1611-x","volume":"308","author":"TS Wang","year":"2016","unstructured":"Wang TS, Chiu HY, Hong JB, Chan CC, Lin SJ, Tsai TF. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res. 2016;308(1):55\u201363.","journal-title":"Arch Dermatol Res."},{"issue":"3","key":"503_CR44","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","volume":"143","author":"S Twelves","year":"2019","unstructured":"Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143(3):1021\u20136.","journal-title":"J Allergy Clin Immunol."},{"issue":"10","key":"503_CR45","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/jid.2015.186","volume":"135","author":"R Mossner","year":"2015","unstructured":"Mossner R, Frambach Y, Wilsmann-Theis D, Lohr S, Jacobi A, Weyergraf A, et al. Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients. J Investig Dermatol. 2015;135(10):2538\u201341.","journal-title":"J Investig Dermatol."},{"issue":"6","key":"503_CR46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/ced.13926","volume":"44","author":"R Tobita","year":"2019","unstructured":"Tobita R, Egusa C, Maeda T, Abe N, Sakai N, Suzuki S, et al. A novel CARD14 variant, homozygous c.526G\u00a0>\u00a0C (p.Asp176His), in an adolescent Japanese patient with palmoplantar pustulosis. Clin Exp Dermatol. 2019;44(6):694\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"503_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","volume":"120","author":"K Asumalahti","year":"2003","unstructured":"Asumalahti K, Ameen M, Suomela S, Hagforsen E, Micha\u00eblsson G, Evans J, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Investig Dermatol. 2003;120(4):627\u201332.","journal-title":"J Investig Dermatol."},{"issue":"1","key":"503_CR48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.0022-202X.2004.23556.x","volume":"124","author":"R M\u00f6ssner","year":"2005","unstructured":"M\u00f6ssner R, Kingo K, Kleensang A, Kr\u00fcger U, K\u00f6nig IR, Silm H, et al. Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris [6]. J Investig Dermatol. 2005;124(1):282\u20134.","journal-title":"J Investig Dermatol."},{"issue":"13","key":"503_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.4103\/0366-6999.184470","volume":"129","author":"JW Han","year":"2016","unstructured":"Han JW, Wang Y, Alateng C, Li HB, Bai YH, Lyu XX, et al. Tumor necrosis factor-alpha induced protein 3 interacting protein 1 gene polymorphisms and pustular psoriasis in Chinese Han population. Chin Med J (Engl). 2016;129(13):1519\u201324.","journal-title":"Chin Med J (Engl)."},{"issue":"5","key":"503_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/1346-8138.14850","volume":"46","author":"K Masuda-Kuroki","year":"2019","unstructured":"Masuda-Kuroki K, Murakami M, Kishibe M, Kobayashi S, Okubo Y, Yamamoto T, et al. Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx. J Dermatol. 2019;46(5):399\u2013408.","journal-title":"J Dermatol."},{"issue":"8","key":"503_CR51","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1468-3083.2012.04702.x","volume":"27","author":"SY Yoon","year":"2013","unstructured":"Yoon SY, Park HS, Yoon HS, Chung JH, Cho S. Utility of epithelial membrane antigen immunostaining in the differentiation between palmoplantar pustulosis and pompholyx. J Eur Acad Dermatol Venereol. 2013;27(8):1054\u20136.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"7","key":"503_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1468-3083.2012.04602.x","volume":"27","author":"SY Yoon","year":"2013","unstructured":"Yoon SY, Park HS, Lee JH, Cho S. Histological differentiation between palmoplantar pustulosis and pompholyx. J Eur Acad Dermatol Venereol. 2013;27(7):889\u201393.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"12","key":"503_CR53","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jdv.12203","volume":"27","author":"DY Kim","year":"2013","unstructured":"Kim DY, Kim JY, Kim TG, Kwon JE, Sohn H, Park J, et al. A comparison of inflammatory mediator expression between palmoplantar pustulosis and pompholyx. J Eur Acad Dermatol Venereol. 2013;27(12):1559\u201365.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"8","key":"503_CR54","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/jid.2010.87","volume":"130","author":"M Murakami","year":"2010","unstructured":"Murakami M, Ohtake T, Horibe Y, Ishida-Yamamoto A, Morhenn VB, Gallo RL, et al. Acrosyringium is the main site of the vesicle\/pustule formation in palmoplantar pustulosis. J Investig Dermatol. 2010;130(8):2010\u20136.","journal-title":"J Investig Dermatol."},{"issue":"3","key":"503_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2133.2002.04640.x","volume":"146","author":"E Hagforsen","year":"2002","unstructured":"Hagforsen E, Edvinsson M, Nordlind K, Micha\u00eblsson G. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol. 2002;146(3):383\u201391.","journal-title":"Br J Dermatol."},{"issue":"2","key":"503_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1365-2133.2000.03290.x","volume":"142","author":"E Hagforsen","year":"2000","unstructured":"Hagforsen E, Einarsson A, Aronsson F, Nordlind K, Michaelsson G. The distribution of choline acetyltransferase- and acetylcholinesterase-like immunoreactivity in the palmar skin of patients with palmoplantar pustulosis. Br J Dermatol. 2000;142(2):234\u201342.","journal-title":"Br J Dermatol."},{"issue":"3","key":"503_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2133.2010.09819.x","volume":"163","author":"E Hagforsen","year":"2010","unstructured":"Hagforsen E, Hedstrand H, Nyberg F, Michaelsson G. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis. Br J Dermatol. 2010;163(3):572\u20139.","journal-title":"Br J Dermatol."},{"issue":"6","key":"503_CR58","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10875-010-9451-0","volume":"30","author":"S Ueda","year":"2010","unstructured":"Ueda S, Takahara M, Tohtani T, Yoshizaki T, Kishibe K, Harabuchi Y. Up-regulation of \u03b21 integrin on tonsillar T cells and its induction by in vitro stimulation with \u03b1-streptococci in patients with pustulosis palmaris et plantaris. J Clin Immunol. 2010;30(6):861\u201371.","journal-title":"J Clin Immunol."},{"issue":"1","key":"503_CR59","first-page":"71","volume":"157","author":"T Yoshizaki","year":"2009","unstructured":"Yoshizaki T, Bandoh N, Ueda S, Nozawa H, Goto T, Kishibe K, et al. Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with \u03b1-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Dermatol. 2009;157(1):71\u201382.","journal-title":"Clin Exp Dermatol."},{"issue":"2","key":"503_CR60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clim.2005.01.001","volume":"115","author":"M Takahara","year":"2005","unstructured":"Takahara M, Kishibe K, Nozawa H, Harabuchi Y. Increase of activated T-cells and up-regulation of Smad7 without elevation of TGF-beta expression in tonsils from patients with pustulosis palmaris et plantaris. Clin Immunol. 2005;115(2):192\u20139.","journal-title":"Clin Immunol."},{"issue":"1","key":"503_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jdermsci.2016.09.019","volume":"85","author":"R Bissonnette","year":"2017","unstructured":"Bissonnette R, Fuentes-Duculan J, Mashiko S, Li X, Bonifacio KM, Cueto I, et al. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway. J Dermatol Sci. 2017;85(1):20\u20136.","journal-title":"J Dermatol Sci."},{"issue":"10","key":"503_CR62","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/jdv.12272","volume":"28","author":"R Bissonnette","year":"2014","unstructured":"Bissonnette R, Nigen S, Langley RG, Lynde CW, Tan J, Fuentes-Duculan J, et al. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol. 2014;28(10):1298\u2013305.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"503_CR63","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol. 2011;187(1):490\u2013500.","journal-title":"J Immunol."},{"issue":"3","key":"503_CR64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000087019","volume":"211","author":"M Ozawa","year":"2005","unstructured":"Ozawa M, Terui T, Tagami H. Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris. Dermatology. 2005;211(3):249\u201355.","journal-title":"Dermatology."},{"issue":"10","key":"503_CR65","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","volume":"20","author":"M Murakami","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V, Ishida-Yamamoto A, Iizuka H. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol. 2011;20(10):845\u20137.","journal-title":"Exp Dermatol."},{"issue":"10","key":"503_CR66","doi-asserted-by":"publisher","first-page":"e110677","DOI":"10.1371\/journal.pone.0110677","volume":"9","author":"M Murakami","year":"2014","unstructured":"Murakami M, Kaneko T, Nakatsuji T, Kameda K, Okazaki H, Dai X, et al. Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. PLoS One. 2014;9(10):e110677.","journal-title":"PLoS One."},{"issue":"1","key":"503_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/ced.13689","volume":"44","author":"Y Xiaoling","year":"2019","unstructured":"Xiaoling Y, Chao W, Wenming W, Feng L, Hongzhong J. Interleukin (IL)-8 and IL-36\u03b3 but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis. Clin Exp Dermatol. 2019;44(1):52\u20137.","journal-title":"Clin Exp Dermatol."},{"issue":"2","key":"503_CR68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/etm.2011.402","volume":"3","author":"WG Jiang","year":"2012","unstructured":"Jiang WG, Sanders AJ, Ruge F, Harding KG. Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-gamma and potential clinical implications. Exp Ther Med. 2012;3(2):231\u20136.","journal-title":"Exp Ther Med."},{"issue":"1","key":"503_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jdermsci.2017.12.018","volume":"90","author":"K Wolk","year":"2018","unstructured":"Wolk K, Frambach Y, Jacobi A, Wilsmann-Theis D, Phillipp S, Witte-H\u00e4ndel E, et al. Increased levels of lipocalin 2 in palmoplantar pustular psoriasis. J Dermatol Sci. 2018;90(1):68\u201374.","journal-title":"J Dermatol Sci."},{"issue":"12","key":"503_CR70","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/exd.13791","volume":"27","author":"K Masuda-Kuroki","year":"2018","unstructured":"Masuda-Kuroki K, Murakami M, Tokunaga N, Kishibe M, Mori H, Utsunomiya R, et al. The microbiome of the \u201csterile\u201d pustules in palmoplantar pustulosis. Exp Dermatol. 2018;27(12):1372\u20137.","journal-title":"Exp Dermatol."},{"issue":"1","key":"503_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdermsci.2018.12.003","volume":"93","author":"M Kouno","year":"2019","unstructured":"Kouno M, Akiyama Y, Minabe M, Iguchi N, Nomura T, Ishihara K, et al. Dysbiosis of oral microbiota in palmoplantar pustulosis patients. J Dermatol Sci. 2019;93(1):67\u20139.","journal-title":"J Dermatol Sci."},{"issue":"1","key":"503_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/09546634.2015.1052036","volume":"27","author":"M Muro","year":"2016","unstructured":"Muro M, Kawakami H, Matsumoto Y, Abe N, Tsuboi R, Okubo Y. Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: a prospective, randomized, left-right comparison study. J Dermatol Treat. 2016;27(1):51\u20133.","journal-title":"J Dermatol Treat."},{"issue":"3","key":"503_CR73","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/1346-8138.13064","volume":"43","author":"Y Umezawa","year":"2016","unstructured":"Umezawa Y, Nakagawa H, Tamaki K. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: a randomized, double-blind, placebo-controlled trial. J Dermatol. 2016;43(3):288\u201393.","journal-title":"J Dermatol."},{"issue":"9","key":"503_CR74","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamadermatol.2018.2397","volume":"154","author":"AB Robbins","year":"2018","unstructured":"Robbins AB, Gor A, Bui MR. Topical crisaborole\u2014a potential treatment for recalcitrant palmoplantar psoriasis. JAMA Dermatol. 2018;154(9):1096\u20137.","journal-title":"JAMA Dermatol."},{"issue":"6","key":"503_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archdermatol.2011.120","volume":"147","author":"L Laino","year":"2011","unstructured":"Laino L, DiCarlo A. Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. Arch Dermatol. 2011;147(6):760.","journal-title":"Arch Dermatol."},{"issue":"4","key":"503_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-4632.2004.02153.x","volume":"44","author":"B Engin","year":"2005","unstructured":"Engin B, Oguz O. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. Int J Dermatol. 2005;44(4):337\u20139.","journal-title":"Int J Dermatol."},{"issue":"5","key":"503_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/09546630600866442","volume":"17","author":"K Riad","year":"2006","unstructured":"Riad K, Felix P, Dorit S, Gregory K, Nadim K, Henri T. The use of topical PUVA for palmoplantar dermatoses. J Dermatol Treat. 2006;17(5):304\u20137.","journal-title":"J Dermatol Treat."},{"key":"503_CR78","doi-asserted-by":"crossref","unstructured":"Jensen L, Stensgaard A, Andersen KE. Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses. Dermatol Rep. 2012;4(1).","DOI":"10.4081\/dr.2012.e3"},{"issue":"8","key":"503_CR79","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-4362.2001.01094-3.x","volume":"40","author":"K Ettler","year":"2001","unstructured":"Ettler K, Richards B. Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP. Int J Dermatol. 2001;40(8):541\u20132.","journal-title":"Int J Dermatol."},{"issue":"5","key":"503_CR80","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ad.2012.12.009","volume":"104","author":"JM Carrascosa","year":"2013","unstructured":"Carrascosa JM, Plana A, Ferr\u00e1ndiz C. Effectiveness and safety of psoralen-UVA (PUVA) topical therapy in palmoplantar psoriasis: a report on 48 patients. Actas Dermo-Sifiliograficas. 2013;104(5):418\u201325.","journal-title":"Actas Dermo-Sifiliograficas."},{"issue":"9","key":"503_CR81","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/1346-8138.12228","volume":"40","author":"A Kawada","year":"2013","unstructured":"Kawada A, Matsuda H, Oiso N. Efficacy and safety of targeted narrowband ultraviolet B therapy using a flat-type fluorescent lamp for the treatment of palmoplantar pustulosis. J Dermatol. 2013;40(9):754\u20135.","journal-title":"J Dermatol."},{"issue":"8","key":"503_CR82","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10103-017-2280-0","volume":"32","author":"LN Su","year":"2017","unstructured":"Su LN, Ren J, Cheng SM, Liu JL, Ding YF, Zhu NW. UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Lasers Med Sci. 2017;32(8):1819\u201323.","journal-title":"Lasers Med Sci"},{"issue":"3","key":"503_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/09546634.2015.1093588","volume":"27","author":"A Lozinski","year":"2016","unstructured":"Lozinski A, Barzilai A, Pavlotsky F. Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment. J Dermatol Treat. 2016;27(3):221\u20133.","journal-title":"J Dermatol Treat."},{"issue":"8","key":"503_CR84","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10103-016-2031-7","volume":"31","author":"LN Su","year":"2016","unstructured":"Su LN, Xu X, Tang L, Yu N, Ding YF. UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study. Lasers Med Sci. 2016;31(8):1641\u20133.","journal-title":"Lasers Med Sci."},{"issue":"4","key":"503_CR85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/pho.2008.2317","volume":"27","author":"SP Nistic\u00f2","year":"2009","unstructured":"Nistic\u00f2 SP, Saraceno R, Schipani C, Costanzo A, Chimenti S. Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg. 2009;27(4):647\u201354.","journal-title":"Photomed Laser Surg."},{"issue":"1","key":"503_CR86","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2133.2005.06320.x","volume":"152","author":"F Aubin","year":"2005","unstructured":"Aubin F, Vigan M, Puzenat E, Blanc D, Drobacheff C, Deprez P, et al. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol. 2005;152(1):99\u2013103.","journal-title":"Br J Dermatol."},{"issue":"12","key":"503_CR87","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/1346-8138.12302","volume":"40","author":"T Fumimori","year":"2013","unstructured":"Fumimori T, Tsuruta D, Kawakami T, Ohata C, Furumura M, Hashimoto T. Effect of monochromatic excimer light on palmoplantar pustulosis: a clinical study performed in a private clinic by a dermatological specialist. J Dermatol. 2013;40(12):1004\u20137.","journal-title":"J Dermatol."},{"issue":"9","key":"503_CR88","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1600-0625.2011.01316.x","volume":"20","author":"T Furuhashi","year":"2011","unstructured":"Furuhashi T, Torii K, Kato H, Nishida E, Saito C, Morita A. Efficacy of excimer light therapy (308\u00a0nm) for palmoplantar pustulosis with the induction of circulating regulatory T cells. Exp Dermatol. 2011;20(9):768\u201370.","journal-title":"Exp Dermatol."},{"issue":"5","key":"503_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-0781.2008.00364.x","volume":"24","author":"L Han","year":"2008","unstructured":"Han L, Somani AK, Huang Q, Fang X, Jin Y, Xiang LH, et al. Evaluation of 308-nm monochromatic excimer light in the treatment of psoriasis vulgaris and palmoplantar psoriasis. Photodermatol Photoimmunol Photomed. 2008;24(5):231\u20136.","journal-title":"Photodermatol Photoimmunol Photomed."},{"issue":"1","key":"503_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1346-8138.2007.00213.x","volume":"34","author":"JY Kim","year":"2007","unstructured":"Kim JY, Kang HY, Lee ES, Kim YC. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis. J Dermatol. 2007;34(1):37\u201340.","journal-title":"J Dermatol."},{"issue":"4","key":"503_CR91","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/bjd.17309","volume":"180","author":"TH Wong","year":"2019","unstructured":"Wong TH, Morton CA, Collier N, Haylett A, Ibbotson S, McKenna KE, et al. British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018. Br J Dermatol. 2019;180(4):730\u20139.","journal-title":"Br J Dermatol."},{"issue":"8","key":"503_CR92","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/ced.12960","volume":"41","author":"L Fenton","year":"2016","unstructured":"Fenton L, Dawe RS. Six years\u2019 experience of grenz ray therapy for the treatment of inflammatory skin conditions. Clin Exp Dermatol. 2016;41(8):864\u201370.","journal-title":"Clin Exp Dermatol."},{"issue":"Suppl 5","key":"503_CR93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/jdv.12561","volume":"28","author":"M Sevrain","year":"2014","unstructured":"Sevrain M, Richard MA, Barnetche T, Rouzaud M, Villani AP, Paul C, et al. Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion. J Eur Acad Dermatol Venereol. 2014;28(Suppl 5):13\u20136.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"503_CR94","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1365-2133.2012.11063.x","volume":"167","author":"N Irla","year":"2012","unstructured":"Irla N, Navarini AA, Yawalkar N. Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis. Br J Dermatol. 2012;167(5):1170\u20134.","journal-title":"Br J Dermatol."},{"issue":"6","key":"503_CR95","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/bjd.14401","volume":"174","author":"K Reich","year":"2016","unstructured":"Reich K, Graff O, Mehta N. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomised phase II study. Br J Dermatol. 2016;174(6):1277\u201381.","journal-title":"Br J Dermatol."},{"issue":"2","key":"503_CR96","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/bjd.15605","volume":"177","author":"AMG Brunasso","year":"2017","unstructured":"Brunasso AMG, Massone C. Alitretinoin therapy for palmoplantar pustulosis. Br J Dermatol. 2017;177(2):578\u20139.","journal-title":"Br J Dermatol."},{"key":"503_CR97","doi-asserted-by":"crossref","unstructured":"Obeid G, Do G, Katsahian S, Kirby L, Hughes C, Le Cleach L. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2015;2015(4).","DOI":"10.1002\/14651858.CD011628"},{"issue":"3","key":"503_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/09546634.2012.672710","volume":"24","author":"SC Au","year":"2013","unstructured":"Au SC, Goldminz AM, Kim N, Dumont N, Michelon M, Volf E, et al. Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatol Treat. 2013;24(3):179\u201387.","journal-title":"J Dermatol Treat."},{"issue":"4","key":"503_CR99","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/bjd.12150","volume":"168","author":"C Morales-M\u00fanera","year":"2013","unstructured":"Morales-M\u00fanera C, Vilarrasa E, Puig L. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis. Br J Dermatol. 2013;168(4):820\u20134.","journal-title":"Br J Dermatol."},{"issue":"5","key":"503_CR100","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1111\/jdv.14718","volume":"32","author":"S Hegazy","year":"2018","unstructured":"Hegazy S, Konstantinou MP, Bulai Livideanu C, Tauber M, Uthurriague C, Paul C. Efficacy of ustekinumab in palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2018;32(5):e204\u20136.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"11","key":"503_CR101","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/ddg.12825","volume":"14","author":"V Buder","year":"2016","unstructured":"Buder V, Herberger K, Jacobi A, Augustin M, Radtke MA. Ustekinumab in the treatment of palmoplantar pustular psoriasis\u2014a case series of nine patients. J Dtsch Dermatol Ges. 2016;14(11):1108\u201313.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"10","key":"503_CR102","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1111\/ijd.12511","volume":"53","author":"T Bertelsen","year":"2014","unstructured":"Bertelsen T, Kragballe K, Johansen C, Iversen L. Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis. Int J Dermatol. 2014;53(10):e464\u20136.","journal-title":"Int J Dermatol."},{"issue":"5","key":"503_CR103","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","volume":"163","author":"S Gerdes","year":"2010","unstructured":"Gerdes S, Franke J, Domm S, Mrowietz U. Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol. 2010;163(5):1116\u20138.","journal-title":"Br J Dermatol."},{"issue":"3","key":"503_CR104","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamadermatol.2017.5937","volume":"154","author":"T Terui","year":"2018","unstructured":"Terui T, Kobayashi S, Okubo Y, Murakami M, Hirose K, Kubo H. Efficacy and safety of guselkumab, an anti-interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial. JAMA Dermatol. 2018;154(3):309\u201316.","journal-title":"JAMA Dermatol."},{"key":"503_CR105","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.1394","author":"T Terui","year":"2019","unstructured":"Terui T, Kobayashi S, Okubo Y, Murakami M, Zheng R, Morishima H, et al. Efficacy and safety of guselkumab in Japanese patients with palmoplantar pustulosis: a phase 3 randomized clinical trial. JAMA Dermatol. 2019. https:\/\/doi.org\/10.1001\/jamadermatol.2019.1394.","journal-title":"JAMA Dermatol."},{"issue":"10","key":"503_CR106","first-page":"940","volume":"7","author":"R Bissonnette","year":"2008","unstructured":"Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, et al. Etanercept in the treatment of palmoplantar pustulosis. J Drugs Dermatol. 2008;7(10):940\u20136.","journal-title":"J Drugs Dermatol."},{"issue":"11","key":"503_CR107","first-page":"821","volume":"10","author":"S Philipp","year":"2012","unstructured":"Philipp S, Wilsmann-Theis D, Weyergraf A, Rotterdam S, Frambach Y, Gerdes S, et al. Combination of adalimumab with traditional systemic antipsoriatic drugs\u2014a report of 39 cases. J Dtsch Dermatol Ges. 2012;10(11):821\u201338.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"5","key":"503_CR108","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","volume":"80","author":"U Mrowietz","year":"2019","unstructured":"Mrowietz U, Bachelez H, Burden AD, Rissler M, Sieder C, Orsenigo R, et al. Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: results of the 2PRECISE study. J Am Acad Dermatol. 2019;80(5):1344\u201352.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"503_CR109","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/1346-8138.14815","volume":"46","author":"A Pinter","year":"2019","unstructured":"Pinter A, Wilsmann-Theis D, Peitsch WK, M\u00f6ssner R. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: report on four cases. J Dermatol. 2019;46(4):426\u201330.","journal-title":"J Dermatol."},{"issue":"4","key":"503_CR110","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/2475530318788934","volume":"3","author":"A Alomran","year":"2018","unstructured":"Alomran A, Zancanaro P, Prussick L, Abudu M, Her MJ, Kachuk C, et al. Apremilast in combination with an interleukin 17A inhibitor in the treatment of recalcitrant palmoplantar psoriasis: a chart review. J Psoriasis Psoriatic Arthritis. 2018;3(4):122\u20135.","journal-title":"J Psoriasis Psoriatic Arthritis."},{"issue":"1","key":"503_CR111","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/1346-8138.14516","volume":"46","author":"A Eto","year":"2019","unstructured":"Eto A, Nakao M, Furue M. Three cases of palmoplantar pustulosis successfully treated with apremilast. J Dermatol. 2019;46(1):e29\u201330.","journal-title":"J Dermatol."},{"issue":"4","key":"503_CR112","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/ced.13065","volume":"42","author":"G Haebich","year":"2017","unstructured":"Haebich G, Kalavala M. Successful treatment of refractory palmoplantar pustulosis with apremilast. Clin Exp Dermatol. 2017;42(4):471\u20133.","journal-title":"Clin Exp Dermatol."},{"issue":"1","key":"503_CR113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2475530318806255","volume":"4","author":"AL Mikhailitchenko","year":"2019","unstructured":"Mikhailitchenko AL, Crowley EL, Gooderham MJ. Eight-patient case series of palmoplantar pustulosis treated successfully with apremilast. J Psoriasis Psoriatic Arthritis. 2019;4(1):7\u201310.","journal-title":"J Psoriasis Psoriatic Arthritis."},{"issue":"1","key":"503_CR114","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4049\/jimmunol.181.1.669","volume":"181","author":"L Skov","year":"2008","unstructured":"Skov L, Beurskens FJ, Zachariae COC, Reitamo S, Teeling J, Satijn D, et al. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol. 2008;181(1):669\u201379.","journal-title":"J Immunol."},{"issue":"10","key":"503_CR115","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMc1811317","volume":"380","author":"H Bachelez","year":"2019","unstructured":"Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med. 2019;380(10):981\u20133.","journal-title":"N Engl J Med."},{"issue":"3","key":"503_CR116","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/bjd.13012","volume":"171","author":"M Tauber","year":"2014","unstructured":"Tauber M, Viguier M, Alimova E, Petit A, Liot\u00e9 F, Smahi A, et al. Partial clinical response to anakinra in severe palmoplantar pustular psoriasis. Br J Dermatol. 2014;171(3):646\u20139.","journal-title":"Br J Dermatol."},{"issue":"1","key":"503_CR117","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13063-018-2914-y","volume":"19","author":"V Cornelius","year":"2018","unstructured":"Cornelius V, Wilson R, Cro S, Barker J, Burden D, Griffiths CEM, et al. A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial. Trials. 2018;19(1):534.","journal-title":"Trials."},{"key":"503_CR118","unstructured":"Nct. A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis. 2018. https:\/\/clinicaltrials.gov\/show\/nct03633396."},{"key":"503_CR119","unstructured":"Nct. Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients. 2017. https:\/\/clinicaltrials.gov\/show\/nct03135548."},{"key":"503_CR120","unstructured":"Nct. A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis. 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04015518."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-020-00503-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T17:00:48Z","timestamp":1665680448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-020-00503-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s40257-020-00503-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737307908.793586743","asserted-by":"object"}]},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"1 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"M. Misiak-Galazka, J. Zozula, and L. Rudnicka have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}